- 全部删除
您的购物车当前为空
IAXO-102 是一种 TLR4 拮抗剂,可负向调节 TLR4 信号传导,还可以防止实验性腹主动脉瘤的发展。它抑制 MAPK 和 p65 NF-κB 磷酸化和 TLR4 依赖性促炎蛋白的表达。


为众多的药物研发团队赋能,
让新药发现更简单!
IAXO-102 是一种 TLR4 拮抗剂,可负向调节 TLR4 信号传导,还可以防止实验性腹主动脉瘤的发展。它抑制 MAPK 和 p65 NF-κB 磷酸化和 TLR4 依赖性促炎蛋白的表达。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 838 | In stock | |
| 2 mg | ¥ 1,230 | In stock | |
| 5 mg | ¥ 2,180 | In stock | |
| 10 mg | ¥ 3,490 | In stock | |
| 25 mg | ¥ 5,730 | In stock | |
| 50 mg | ¥ 7,990 | In stock | |
| 100 mg | ¥ 10,700 | In stock |
IAXO-102 相关产品
| 产品描述 | IAXO-102 is a TLR4 antagonist that negatively regulates TLR4 signaling. It inhibits MAPK and p65 NF-κB phosphorylation and expression of TLR4 dependent proinflammatory protein. IAXO-102 also prevents experimental abdominal aortic aneurysm development. |
| 体外活性 | IAXO-102 (10 μM, for 17 hours) suppresses LPS induced pro-inflammatory proteins MCP-1 and IL-8 production in HUVEC. IAXO-102 (1-10 μM, for 2 hours) inhibits MAPK and p65 NF-κB phosphorylation in human umbilical vein endothelial (HUVEC) cells. |
| 体内活性 | IAXO-102 (3 mg/kg/day, s.c. for 28 days) significantly retards Angiotensin II-induced increase in aortic diameter in mice. |
| 分子量 | 585.94 |
| 分子式 | C35H71NO5 |
| CAS No. | 1115270-63-7 |
| Smiles | CCCCCCCCCCCCCCO[C@H]1[C@H](O)[C@@H](CN)O[C@H](OC)[C@@H]1OCCCCCCCCCCCCCC |
| 密度 | 0.96 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: 45 mg/mL (76.8 mM), Sonication is recommended. DMSO: < 1 mg/mL (insoluble or slightly soluble) | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
Ethanol
| |||||||||||||||||||||||||||||||
评论内容